IRIS
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stockBearish
0
Neutral
14
Bullish
0
Bearish
0
Neutral
46
Bullish
0
Bearish
0
Neutral
32
Bullish
0
Bearish
0
Neutral
32
Bullish
0
Bearish
0
Neutral
32
Bullish
0
Bearish
0
Neutral
32
Bullish
0
Investor Presentation
Q4 FY26
Triochem Products Limited is a Mumbai-headquartered manufacturer and exporter of pharmaceutical products, active pharmaceutical ingredients (APIs) and specialty chemicals, operating as a single business segment focused on ethical pharmaceutical manufacturing since incorporation in 1972.
The company reported an exceptional prior-period gain of Rs. 1,116.65 lakhs from monetisation of non-core assets, received fully in cash, which materially drove last year’s profitability and strengthened the balance sheet for strategic redeployment.
Standalone unaudited results for the quarter ended 30 June 2026 show total income of Rs. 16.56 lakhs, profit before tax of Rs. 12.39 lakhs and profit after tax of Rs. 9.48 lakhs, indicating current operating scale is modest relative to the one-off prior-period exceptional item.
Board and audit committee reviewed and approved the quarter results on 14 August 2026, with the statutory auditor issuing an unqualified conclusion, providing formal assurance on the accuracy of the reported quarter figures.
Management has signalled intent to deploy proceeds from earlier asset sales toward funding new business ventures and strategic initiatives, suggesting a transition plan to diversify operations beyond legacy non-core asset realisations.
Pharmaceuticals & Biotechnology
Pharmaceuticals
0 Cr
—
0.1
39.5
—
0.0
—
—
Sales CAGR
Profit CAGR
ROE
ROCE
Triochem Products Ltd (TRIPR) is currently trading at N/A per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Triochem Products Limited is a Mumbai-headquartered manufacturer and exporter of pharmaceutical products, active pharmaceutical ingredients (APIs) and specialty chemicals, operating as a single business segment focused on ethical pharmaceutical manufacturing since incorporation in 1972. The company reported an exceptional prior-period gain of Rs. 1,116.65 lakhs from monetisation of non-core assets, received fully in cash, which materially drove last year’s profitability and strengthened the balance sheet for strategic redeployment. Standalone unaudited results for the quarter ended 30 June 2026 show total income of Rs. 16.56 lakhs, profit before tax of Rs. 12.39 lakhs and profit after tax of Rs. 9.48 lakhs, indicating current operating scale is modest relative to the one-off prior-period exceptional item. Board and audit committee reviewed and approved the quarter results on 14 August 2026, with the statutory auditor issuing an unqualified conclusion, providing formal assurance on the accuracy of the reported quarter figures. Management has signalled intent to deploy proceeds from earlier asset sales toward funding new business ventures and strategic initiatives, suggesting a transition plan to diversify operations beyond legacy non-core asset realisations.
Over the past 52 weeks, Triochem Products Ltd has traded between a low of ₹0.00 and a high of ₹0.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Triochem Products Ltd has a market capitalization of approximately 0.43. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Triochem Products Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 0.05 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 0.43 Cr, Triochem Products Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Triochem Products Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Triochem Products Ltd is 0.05. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Triochem Products reported profit after tax of Rs 8.40 lakh for the quarter ended 30 September 2026. The company had reported a Rs 19.26 lakh loss in the corresponding quarter ended 30 September 2025. Profit after tax was Rs 9.48 lakh in the preceding June 2026 quarter.
Triochem Products Limited’s Board of Directors is scheduled to meet on Wednesday, November 4, 2026, at 3:00 p.m. The meeting is to be held at the company’s registered office.
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
12.50 | 7 Cr | 73.90 | 0.89 | 0.00 | 1.14 | 2.54 | 1.02 | ||
22.00 | 7 Cr | 8.15 | 1.46 | 0.00 | 18.05 | -2.59 | 4.23 | ||
1.47 | 6 Cr | 147.00 | 1.27 | 0.00 | 0.60 | 3.76 | 0.14 | ||
5.50 | 6 Cr | -1.81 | 0.27 | 0.00 | -14.93 | -17.41 | -12.62 | ||
20.31 | 4 Cr | -7.62 | 1.17 | 0.00 | -15.32 | -11.50 | -2.53 | ||
3.50 | 4 Cr | 39.11 | 0.34 | 0.00 | 1.11 | 1.49 | 1.16 | ||
— | 0 Cr | 0.05 | 0.02 | 0.00 | -0.61 | -0.18 | 38.20 | ||
| Median: 7 Co. | — | 9.00 | 6 Cr | 8.15 | 0.89 | 0.00 | 0.60 | -0.18 | 1.02 |
